Insmed (INSM) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $24.92 -3.45%
Revenue Growth %: +20.6%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +20.6%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.61), $0.02 worse than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Data I/o Corp (DAIO) Misses Q2 EPS by 7c
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
